Headache News and Research

Latest Headache News and Research

Study points out the need to recognize TBI as a chronic condition

People with TBI may continue to improve or decline years after their injury, making it a more chronic illness, according to a study published in the June 21, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

21 Jun 2023

Hypertension drug shown to prevent post-traumatic headaches

A study led by VA Puget Sound Health Care System researchers has shown that prazosin, a drug used to treat high blood pressure, can prevent posttraumatic headaches.

21 Jun 2023

Study reveals patterns of high blood pressure in pregnant women, linked to maternal health risks

Research examines the trajectory of systolic blood pressure in pregnant women and its associations with various factors. It sheds light on the patterns and risks related to blood pressure during pregnancy.

20 Jun 2023

CDC raises alarm: poor vaccine coverage fuels surge in meningococcal disease among HIV-infected individuals

CDC presents preliminary data showing an increase in meningococcal disease among human immunodeficiency virus (HIV)-infected individuals.

19 Jun 2023

Differences in olfactory abilities in men and women

Researchers compared the responses of men and women to various olfactory stimulations.

6 Jun 2023

CDC reports an alarming rise in pediatric intracranial infections in the U.S.

Researchers confirm the occurrence of a cluster of intracranial infections and identify the risk factors responsible for this increase.

5 Jun 2023

New data from the nationwide INSPIRE study shows Long COVID is not a singular condition

The latest data from the nationwide INSPIRE study assessing the long-term symptoms and outcomes of the COVID-19 virus in nearly 6000 participants identifies four clinically distinct symptom presentations (phenotypes), adding to the growing body evidence that Long COVID is not singular condition but rather a range of conditions that may evolve, and typically improve, over time.

5 Jun 2023

Study of immunotherapy for brain cancer metastases shows promising results

In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving longer than two years.

2 Jun 2023

Understanding factors associated with long-term opioid use in fibromyalgia patients

Fibromyalgia is common, affecting around 2% of people in the general population. The 2017 EULAR recommendations state that tramadol - a weak opioid - may be considered for pain management in fibromyalgia, but advise against use of strong opioids due to lack of evidence of efficacy, and the high risk of side effects and addiction.

2 Jun 2023

Juicy findings: Chinese consumers embrace fruit peel delights, scientists examine nutritional value and pesticide concerns

Research explores the consumption of fruit peels by Chinese consumers, highlighting their nutritional value and pesticide residues. It provides insights into methods of pesticide detection and removal, as well as the physiological benefits of fruit peels, aiming to guide informed consumption and contribute to further research in this area.

1 Jun 2023

Is healthy sleep, both before and during the COVID-19 pandemic, prior to SARS-CoV-2 infection, protective against post–COVID-19 condition?

Researchers examined the relationship between multidimensional sleep health and post-coronavirus disease 2019 condition.

1 Jun 2023

$Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine$

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single centre study, published in the open access journal Regional Anesthesia & Pain Medicine.

30 May 2023

Web-based surveys offer a feasible way to monitor the safety of novel vaccines

Web-based surveys are a feasible way of rapidly collecting drug safety data on novel vaccines when they are rolled out quickly over a large area, according to a new European study involving the UK’s leading drug safety unit.

26 May 2023

Study identifies six odor categories associated with migraine attacks

Researchers categorized migraine-associated odors into six groups.

26 May 2023

Post-COVID condition varies by variant and vaccination status

Research investigates the post-COVID-19 condition, analyzing its profiles based on viral variants and vaccination status. Understanding these profiles can aid in personalized patient care.

17 May 2023

Redefining menstrual migraines: New criteria for accurate diagnosis and improved treatment response

Menstrual migraine, a specific type of migraine affecting women, leads to significant disability and impacts the quality of life during reproductive stages. Understanding its prevalence and impact is crucial for effective management.

17 May 2023

Caffeine connection: Pre-teen caffeine consumption linked to early nicotine use

Research explores the relationship between caffeine use and nicotine onset among early adolescents, shedding light on a potential contributing factor to youth nicotine initiation. It emphasizes the importance of understanding the influence of caffeine in preventing early nicotine use.

16 May 2023

Long-COVID's crippling aftermath: Study reveals persistent symptoms severely impact quality of life, especially in women

Research examines the impact of long-Covid syndrome on the health-related quality of life (HRQoL) of patients with mild or moderate SARS-CoV-2 infections. It reveals significant impairments in physical and mental health, emphasizing the need for long-term surveillance and support for affected individuals.

16 May 2023

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy was safe and improved survival outcomes in a subset of patients with recurrent GBM, according to results from a multi-institutional Phase I/II clinical trial co-led by researchers at The University of Texas MD Anderson Cancer Center and the University of Toronto.

15 May 2023

Pioneering AI-based approach identifies rare disease patients using electronic health records

Research paper describes the use of Symptoma's AI-based approach to identify patients with Pompe disease from retrospective electronic health records. The study found a prevalence of one in every 18,427 people for Pompe disease in the greater Salzburg region and established phenotypes for patient cohorts with an onset of symptoms above or below 1 year of age.

11 May 2023

Headache News and Research

Latest Headache News and Research

Study points out the need to recognize TBI as a chronic condition

Hypertension drug shown to prevent post-traumatic headaches

Study reveals patterns of high blood pressure in pregnant women, linked to maternal health risks

CDC raises alarm: poor vaccine coverage fuels surge in meningococcal disease among HIV-infected individuals

Differences in olfactory abilities in men and women

CDC reports an alarming rise in pediatric intracranial infections in the U.S.

New data from the nationwide INSPIRE study shows Long COVID is not a singular condition

Study of immunotherapy for brain cancer metastases shows promising results

Understanding factors associated with long-term opioid use in fibromyalgia patients

Juicy findings: Chinese consumers embrace fruit peel delights, scientists examine nutritional value and pesticide concerns

Is healthy sleep, both before and during the COVID-19 pandemic, prior to SARS-CoV-2 infection, protective against post–COVID-19 condition?

Study shows ketamine nasal spray as a safe and effective treatment for refractory migraine

Web-based surveys offer a feasible way to monitor the safety of novel vaccines

Study identifies six odor categories associated with migraine attacks

Post-COVID condition varies by variant and vaccination status

Redefining menstrual migraines: New criteria for accurate diagnosis and improved treatment response

Caffeine connection: Pre-teen caffeine consumption linked to early nicotine use

Long-COVID's crippling aftermath: Study reveals persistent symptoms severely impact quality of life, especially in women

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Pioneering AI-based approach identifies rare disease patients using electronic health records

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in